Leading Edge Pharms names former NBA champ to marketing role
Leading Edge Pharms, a company focused on developing new cannabinoid therapies and delivery systems, has added a former NBA champion to its employment roster. The company named John Salley its executive vice president of marketing, effective immediately, and tasked him with helping market Leading Edge Pharms’ Cananvera line of CBD-based topical pain and inflammation products.
"I tried Leading Edge's topical oil for a chronic back pain issue that was keeping me awake at night," Salley said. "The bottom line is the product works. The oil eased my discomfort, allowing me to sleep through the night for the first time in years. As I learned more about the company, it became clear that behind the product was a commitment to the science of CBD and a natural approach to improving lives. I'm excited to join the team and look forward to building market momentum for Leading Edge and Cannavera."
Leading Edge said its products use its proprietary Silvidiol compound, a delivery system that allows CBD to reach the site of pain without systemic absorption.
"We were excited when John expressed interest in joining Leading Edge," said David Chadwick, CEO of Leading Edge. "Obviously, the initial association is basketball and the sports pain relief market. However, John has long since transcended that to focus on audiences looking for natural lifestyle solutions. In John, we are joined by someone who is committed to healthy living and will be a great brand ambassador for the company."